Cargando…
Cetuximab as salvage monotherapy in chemotherapy-refractory metastatic colorectal cancer: A single-center report
In July 2008, cetuximab, a monoclonal antibody against epidermal growth factor receptor (EGFR), was approved in Japan for clinical use against chemotherapy-refractory metastatic colorectal cancer (mCRC). At Shiga University of Medical Science, between December 2007 and April 2012, a total of 24 EGFR...
Autores principales: | MEKATA, EIJI, ENDO, YOSHIHIRO, SONODA, HIROMICHI, SHIMIZU, TOMOHARU, KAWAI, YUKI, UMEDA, TOMOKO, SHIOMI, HISANORI, NAKA, SHIGEYUKI, KUBOTA, YOSHIHIRO, MURATA, SATOSHI, YAMAMOTO, HIROSHI, ABE, HAJIME, TANI, TOHRU |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796414/ https://www.ncbi.nlm.nih.gov/pubmed/24137455 http://dx.doi.org/10.3892/ol.2013.1477 |
Ejemplares similares
-
Differences in Chemosensitivity between Primary and Metastatic Tumors in Colorectal Cancer
por: Takebayashi, Katsushi, et al.
Publicado: (2013) -
Safety and efficacy of panitumumab therapy after metastatic colorectal cancer progression with cetuximab: Experience at a single Japanese institution
por: SONODA, HIROMICHI, et al.
Publicado: (2013) -
A complete response to mFOLFOX6 and panitumumab chemotherapy in advanced stage rectal adenocarcinoma: a case report
por: Sonoda, Hiromichi, et al.
Publicado: (2014) -
Clinical predictive value of in vitro anticancer drug sensitivity test for the therapeutic effect of adjuvant chemotherapy in patients with stage II–III colorectal cancer
por: MEKATA, EIJI, et al.
Publicado: (2013) -
Successful surgical approach for a patient with encapsulating peritoneal sclerosis after hyperthermic intraperitoneal chemotherapy: a case report and literature review
por: Takebayashi, Katsushi, et al.
Publicado: (2014)